Literature DB >> 2888464

The cell biology of multiple drug resistance.

W T Beck.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2888464     DOI: 10.1016/0006-2952(87)90198-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  58 in total

1.  Phenotypic variations dictate the intracellular compartmentalization of doxorubicin in normal human bone marrow cells.

Authors:  E Aghaï; Z A Tökés
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  p-Glycoprotein expression as a predictor of breast cancer recurrence.

Authors:  S Gregorcyk; Y Kang; D Brandt; P Kolm; G Singer; R R Perry
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

3.  Intracellular pH and the control of multidrug resistance.

Authors:  S Simon; D Roy; M Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Photoaffinity labeling of the multidrug-resistance-related P-glycoprotein with photoactive analogs of verapamil.

Authors:  A R Safa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells.

Authors:  Xiaoming Shi; Shengchun Wu; Yongbin Yang; Lei Tang; Yüexin Wang; Junjie Dong; Bonan Lü; Guangwei Jiang; Wei Zhao
Journal:  Tumour Biol       Date:  2014-04-23

6.  Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.

Authors:  J Tarasiuk; B Stefańska; I Plodzich; K Tkaczyk-Gobis; O Seksek; S Martelli; A Garnier-Suillerot; E Borowski
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  Influence of nifedipine on plasma membrane fluidity and oxidative burst of polymorphonuclear leucocytes.

Authors:  W Grassi; R Serretti; P Core; S Muti; C Cervini
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

8.  Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.

Authors:  G J Finlay; K M Holdaway; B C Baguley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  Prediction of the resistance of human tumors to adriamycin by chemosensitivity tests and DNA analysis of the multidrug resistance gene.

Authors:  R Kim; T Saeki; S Takagami; Y Kirihara; K Jinushi; M Nishiyama; M Niimoto; T Hattori; K Okada
Journal:  Jpn J Surg       Date:  1990-03

10.  Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.

Authors:  E C Sha; M C Sha; S H Kaufmann
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.